Answers are grounded in this paper and cite their sources.
Bevacizumab has inhibitory effects on VEGF receptor activation and vascular permeability, and induces apoptosis in tumor cells.
No takes yet. Share an insight, caveat, or question.
Wedam et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: